Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Enrollment completed in safety study of EOquin in noninvasive bladder cancer

Feb. 12, 2007

Sutent approved with new data for advanced renal cell carcinoma

Feb. 9, 2007

Japanese study supports further evaluation of hypertension chemotherapy

Feb. 9, 2007

Kallikrein 6 studied as a prognostic marker and a therapeutic target in ovarian cancer

Feb. 9, 2007

Seliciclib to be investigated for nasopharyngeal cancer

Feb. 9, 2007

UCB and ImClone terminate CDP-791 agreement

Feb. 9, 2007

Pro-Pharmaceuticals commences NDA filing for Davanat

Feb. 8, 2007

European label extension sought for Evoltra for elderly patients with AML

Feb. 8, 2007

Romidepsin studied with bortezomib for relapsed/refractory multiple myeloma

Feb. 8, 2007

Genta to appeal Genasense non-approvable letter in CLL

Feb. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...